ESR2 and neoplasm: Moreover, the results from in vivo study revealed that in contrast to the co-treatment of sh-NC, treatment of sh-PES1 resulted in elevated PES1 expression and decreased tumor growth rate and tumor volume, while co-treatment of sh-NC and PHTPP downregulated ERβ expression and increased tumor growth rate and tumor volume (p < 0.05).